EBOSF - EBOS Group Limited

Other OTC - Other OTC Delayed price. Currency in USD

EBOS Group Limited

737 Bourke Street
Level 7
Docklands, VIC 3008
61 3 9918 5555

Full-time employees5,000

Key executives

NameTitlePayExercisedYear born
Mr. John CullityChief Exec. Officer2.16MN/AN/A
Mr. Leonard HansenCFO & Chief AccountantN/AN/AN/A
Ms. Andrea BellChief Information OfficerN/AN/AN/A
Martin KrauskopfExec. GM of Strategy, Mergers & Acquisitions and GM of Investor RelationsN/AN/AN/A
Ms. Janelle CainGen. CounselN/AN/AN/A
Ms. Jacinta McCarthyGroup Gen. Mang. of HRN/AN/AN/A
Mr. Simon BundeExec. Gen. Mang. of Strategic Operations, ESG & InnovationN/AN/AN/A
Ms. Julie DillonChief Exec. Officer of Animal CareN/AN/AN/A
Mr. Matthew MuscioChief Exec. Officer of Medical TechnologyN/AN/AN/A
Mr. Brett BaronsChief Exec. Officer of SymbionN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and internationally. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition and food products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Corporate governance

EBOS Group Limited’s ISS governance QualityScore as of 1 June 2023 is 10. The pillar scores are Audit: 4; Board: 10; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.